Genetics and epigenetics: Basic concepts

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Genetics is fundamental to our understanding of human variation, and by linking medical and evolutionary themes, it enables us to understand the origins and impacts of our genomic differences. The types of genetic variations used in genetic studies have changed over the last 20 years and can be classified into five major classes: RFLP (restriction fragment length polymorphism), VNTR (variable number of tandem repeat), STR (short tandem repeat or microsatellite), SNP (single- nucleotide polymorphism), and CNV (copy-number variation). Genetic linkage analysis using these tools helped to map and discover genes responsible for hundreds of hereditary diseases. Furthermore, construction of the international SNP database and recent development of high-throughput SNP typing platforms enabled us to perform genome-wide association studies, which have identified genes (or genetic variations) susceptible to common diseases. Moreover, in recent years genome-wide sequencing of individual DNAs is gaining relevant scope. Likewise, epigenetic factors determined by gene-environment interactions, including systematic exposures or chance encounters with environmental factors in one's surroundings, add even more complexity to individual disease risk and the pattern of disease inheritance. Epigenetics comprises the investigation of chemical modifications in the DNA and histones that regulates the gene expression or cellular phenotype. Genetics and epigenetics, together with their newly designed technologies capable to analyze changes, have disclosed an appealing scenario that will offer for the biomedical sciences new insight for the study of neurodegenerative diseases, multifactorial complex diseases, and rare diseases. In this chapter, the main genetic and epigenetic variations will be overviewed together with the technologies adapted for their study, and the use of their modifications as possible biomarkers in several diseases will be summarized.

Original languageEnglish
Title of host publicationNeurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
PublisherSpringer-Verlag London Ltd
Pages1-15
Number of pages15
ISBN (Print)9781447163800, 1447163796, 9781447163794
DOIs
Publication statusPublished - Mar 1 2014

Fingerprint

Epigenomics
Single Nucleotide Polymorphism
Microsatellite Repeats
Technology
Inheritance Patterns
Gene-Environment Interaction
Minisatellite Repeats
Inborn Genetic Diseases
Genetic Linkage
Genome-Wide Association Study
Rare Diseases
DNA Sequence Analysis
Restriction Fragment Length Polymorphisms
Neurodegenerative Diseases
Histones
Genes
Biomarkers
Genome
Databases
Phenotype

Keywords

  • C9ORF72
  • Frontotemporal lobar degeneration
  • Genetics
  • Progranulin ( GRN )
  • Risk factor
  • Tau

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Fenoglio, C. (2014). Genetics and epigenetics: Basic concepts. In Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers (pp. 1-15). Springer-Verlag London Ltd. https://doi.org/10.1007/978-1-4471-6380-0_1

Genetics and epigenetics : Basic concepts. / Fenoglio, Chiara.

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers. Springer-Verlag London Ltd, 2014. p. 1-15.

Research output: Chapter in Book/Report/Conference proceedingChapter

Fenoglio, C 2014, Genetics and epigenetics: Basic concepts. in Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers. Springer-Verlag London Ltd, pp. 1-15. https://doi.org/10.1007/978-1-4471-6380-0_1
Fenoglio C. Genetics and epigenetics: Basic concepts. In Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers. Springer-Verlag London Ltd. 2014. p. 1-15 https://doi.org/10.1007/978-1-4471-6380-0_1
Fenoglio, Chiara. / Genetics and epigenetics : Basic concepts. Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers. Springer-Verlag London Ltd, 2014. pp. 1-15
@inbook{e252318fb34b46498b3b1d750d532232,
title = "Genetics and epigenetics: Basic concepts",
abstract = "Genetics is fundamental to our understanding of human variation, and by linking medical and evolutionary themes, it enables us to understand the origins and impacts of our genomic differences. The types of genetic variations used in genetic studies have changed over the last 20 years and can be classified into five major classes: RFLP (restriction fragment length polymorphism), VNTR (variable number of tandem repeat), STR (short tandem repeat or microsatellite), SNP (single- nucleotide polymorphism), and CNV (copy-number variation). Genetic linkage analysis using these tools helped to map and discover genes responsible for hundreds of hereditary diseases. Furthermore, construction of the international SNP database and recent development of high-throughput SNP typing platforms enabled us to perform genome-wide association studies, which have identified genes (or genetic variations) susceptible to common diseases. Moreover, in recent years genome-wide sequencing of individual DNAs is gaining relevant scope. Likewise, epigenetic factors determined by gene-environment interactions, including systematic exposures or chance encounters with environmental factors in one's surroundings, add even more complexity to individual disease risk and the pattern of disease inheritance. Epigenetics comprises the investigation of chemical modifications in the DNA and histones that regulates the gene expression or cellular phenotype. Genetics and epigenetics, together with their newly designed technologies capable to analyze changes, have disclosed an appealing scenario that will offer for the biomedical sciences new insight for the study of neurodegenerative diseases, multifactorial complex diseases, and rare diseases. In this chapter, the main genetic and epigenetic variations will be overviewed together with the technologies adapted for their study, and the use of their modifications as possible biomarkers in several diseases will be summarized.",
keywords = "C9ORF72, Frontotemporal lobar degeneration, Genetics, Progranulin ( GRN ), Risk factor, Tau",
author = "Chiara Fenoglio",
year = "2014",
month = "3",
day = "1",
doi = "10.1007/978-1-4471-6380-0_1",
language = "English",
isbn = "9781447163800",
pages = "1--15",
booktitle = "Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers",
publisher = "Springer-Verlag London Ltd",

}

TY - CHAP

T1 - Genetics and epigenetics

T2 - Basic concepts

AU - Fenoglio, Chiara

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Genetics is fundamental to our understanding of human variation, and by linking medical and evolutionary themes, it enables us to understand the origins and impacts of our genomic differences. The types of genetic variations used in genetic studies have changed over the last 20 years and can be classified into five major classes: RFLP (restriction fragment length polymorphism), VNTR (variable number of tandem repeat), STR (short tandem repeat or microsatellite), SNP (single- nucleotide polymorphism), and CNV (copy-number variation). Genetic linkage analysis using these tools helped to map and discover genes responsible for hundreds of hereditary diseases. Furthermore, construction of the international SNP database and recent development of high-throughput SNP typing platforms enabled us to perform genome-wide association studies, which have identified genes (or genetic variations) susceptible to common diseases. Moreover, in recent years genome-wide sequencing of individual DNAs is gaining relevant scope. Likewise, epigenetic factors determined by gene-environment interactions, including systematic exposures or chance encounters with environmental factors in one's surroundings, add even more complexity to individual disease risk and the pattern of disease inheritance. Epigenetics comprises the investigation of chemical modifications in the DNA and histones that regulates the gene expression or cellular phenotype. Genetics and epigenetics, together with their newly designed technologies capable to analyze changes, have disclosed an appealing scenario that will offer for the biomedical sciences new insight for the study of neurodegenerative diseases, multifactorial complex diseases, and rare diseases. In this chapter, the main genetic and epigenetic variations will be overviewed together with the technologies adapted for their study, and the use of their modifications as possible biomarkers in several diseases will be summarized.

AB - Genetics is fundamental to our understanding of human variation, and by linking medical and evolutionary themes, it enables us to understand the origins and impacts of our genomic differences. The types of genetic variations used in genetic studies have changed over the last 20 years and can be classified into five major classes: RFLP (restriction fragment length polymorphism), VNTR (variable number of tandem repeat), STR (short tandem repeat or microsatellite), SNP (single- nucleotide polymorphism), and CNV (copy-number variation). Genetic linkage analysis using these tools helped to map and discover genes responsible for hundreds of hereditary diseases. Furthermore, construction of the international SNP database and recent development of high-throughput SNP typing platforms enabled us to perform genome-wide association studies, which have identified genes (or genetic variations) susceptible to common diseases. Moreover, in recent years genome-wide sequencing of individual DNAs is gaining relevant scope. Likewise, epigenetic factors determined by gene-environment interactions, including systematic exposures or chance encounters with environmental factors in one's surroundings, add even more complexity to individual disease risk and the pattern of disease inheritance. Epigenetics comprises the investigation of chemical modifications in the DNA and histones that regulates the gene expression or cellular phenotype. Genetics and epigenetics, together with their newly designed technologies capable to analyze changes, have disclosed an appealing scenario that will offer for the biomedical sciences new insight for the study of neurodegenerative diseases, multifactorial complex diseases, and rare diseases. In this chapter, the main genetic and epigenetic variations will be overviewed together with the technologies adapted for their study, and the use of their modifications as possible biomarkers in several diseases will be summarized.

KW - C9ORF72

KW - Frontotemporal lobar degeneration

KW - Genetics

KW - Progranulin ( GRN )

KW - Risk factor

KW - Tau

UR - http://www.scopus.com/inward/record.url?scp=84930589815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930589815&partnerID=8YFLogxK

U2 - 10.1007/978-1-4471-6380-0_1

DO - 10.1007/978-1-4471-6380-0_1

M3 - Chapter

AN - SCOPUS:84930589815

SN - 9781447163800

SN - 1447163796

SN - 9781447163794

SP - 1

EP - 15

BT - Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

PB - Springer-Verlag London Ltd

ER -